Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders

Cell Metabolism

Volumn 14, Issue 6, 2011, Pages 715-716

  Djouadi, Fatima ^a   Bastin, Jean ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE;

CARCINOGENIC ACTIVITY; CELL PROLIFERATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; LETTER; LIVER TOXICITY; LONG TERM EXPOSURE; MYALGIA; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY CHAIN; RHABDOMYOLYSIS; SKELETAL MUSCLE; SPECIES DIFFERENCE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYTOCHROME-C OXIDASE DEFICIENCY; ELECTRON TRANSPORT COMPLEX IV; TRANS-ACTIVATORS;

EID: 82955193720     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.11.003     Document Type: Letter

References (5)

1. J. Bastin, F. Aubey, A. Rotig, A. Munnich, and F. Djouadi J. Clin. Endocrinol. Metab. 93 2008 1433 1441
2. J.P. Bonnefont, J. Bastin, P. Laforet, F. Aubey, A. Mogenet, S. Romano, D. Ricquier, S. Gobin-Limballe, A. Vassault, and A. Behin Clin. Pharmacol. Ther. 88 2010 101 108
3. T. Hays, I. Rusyn, A.M. Burns, M.J. Kennett, J.M. Ward, F.J. Gonzalez, and J.M. Peters Carcinogenesis 26 2005 219 227
4. T. Nakajima, N. Tanaka, H. Kanbe, A. Hara, Y. Kamijo, X. Zhang, F.J. Gonzalez, and T. Aoyama Mol. Pharmacol. 75 2009 782 792
5. C. Viscomi, E. Bottani, G. Civiletto, R. Cerutti, M. Moggio, G. Fagiolari, E.A. Schon, C. Lamperti, and M. Zeviani Cell Metab. 14 2011 80 90